Exelixis (EXEL) Assets (2010 - 2026)
Exelixis (EXEL) recorded quarterly Assets of $2.6 billion in Q2 2026, down 8.82% quarter-over-quarter from $2.8 billion in Q1 2026, and down 8.59% on a YoY basis from $2.8 billion in Q2 2025.
Exelixis (EXEL) Assets (2010 - 2026) Analysis & Trends
Exelixis' Assets history runs 17 years deep, the most recent figure standing at $2.6 billion for Q2 2026.
- In Q2 2026, Assets fell 8.59% year-over-year to $2.6 billion; the TTM figure through Apr 2026 stood at $2.6 billion (down 8.59% YoY), while the FY2026 annual figure was $2.8 billion, down 3.5% from the prior year.
- Assets was $2.6 billion for Q2 2026 at Exelixis, down from $2.8 billion in the prior quarter.
- In the past five years, Assets ranged from a high of $3.1 billion in Q1 2023 to a low of $2.6 billion in Q2 2026.
- Historically, Assets has averaged $2.9 billion across 5 years, with a median of $2.9 billion in 2022.
- The sharpest annual moves came in 2022 and 2024: Assets increased 21.72% in 2022, then decreased 11.75% in 2024.
- A 5-year view of Assets shows it stood at $3.1 billion in 2022, then decreased by 4.2% to $2.9 billion in 2023, then advanced by 0.61% to $3.0 billion in 2024, then slipped by 4.62% to $2.8 billion in 2025, then slipped by 8.14% to $2.6 billion in 2026.
- The last three Assets figures came in at $2.6 billion (Q2 2026), $2.8 billion (Q1 2026), and $2.8 billion (Q4 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | 37.37 Mn |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | 811.27 Mn |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | 14.93 Mn |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 1.73 Bn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | 33.89 Mn |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | 23.64 Mn |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | 12.81 Mn |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 26.48 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | 640.56 Mn |
| 10 | Exelixis | 13.37 Bn | 12.59 Bn | 590.86 Mn | 2.59 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | 2.59 Bn |
| Jan 2, 2026 | 2.84 Bn |
| Oct 3, 2025 | 2.82 Bn |
| Jul 4, 2025 | 2.68 Bn |
| Apr 4, 2025 | 2.84 Bn |
| Jan 3, 2025 | 2.95 Bn |
| Sep 27, 2024 | 2.96 Bn |
| Jun 28, 2024 | 2.77 Bn |
| Mar 29, 2024 | 2.80 Bn |
| Dec 29, 2023 | 2.94 Bn |
| Sep 29, 2023 | 2.98 Bn |
| Jun 30, 2023 | 3.14 Bn |
| Mar 31, 2023 | 3.14 Bn |
| Dec 30, 2022 | 3.07 Bn |
| Sep 30, 2022 | 2.96 Bn |
| Jul 1, 2022 | 2.88 Bn |
| Apr 1, 2022 | 2.65 Bn |
| Dec 31, 2021 | 2.62 Bn |
| Oct 1, 2021 | 2.45 Bn |
| Jul 2, 2021 | 2.37 Bn |